Carbapenemases as factors of Resistance to Antibacterial Drugs
Antibiotic drugs are used to treat and prevent bacterial infections around the world. The emergence and spread of bacterial resistance to carbapenems is currently a real threat that determines the need for its timely detection and suppression. Carbapenem-resistant Enterobacteriaceae, Pseudomonas a...
Guardado en:
Autor principal: | A. V. Nevezhina |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Scientific Сentre for Family Health and Human Reproduction Problems
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fba17456b56f4fb698b8ecb470d259b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
<italic toggle="yes">Klebsiella pneumoniae</italic> Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering
por: Melissa D. Barnes, et al.
Publicado: (2017) -
Identification of extended spectrum beta lactamases, AmpC and carbapenemase production among isolates of Escherichia coli in North Indian tertiary care centre
por: Uma Chaudhary, et al.
Publicado: (2018) -
Development and Evaluation of a Novel Protein-Based Assay for Specific Detection of KPC β-Lactamases from <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Clinical Isolates
por: Shuo Lu, et al.
Publicado: (2020) -
Epidemiology of Extended-Spectrum Beta-Lactamase and Carbapenemase-Producing Enterobacterales in the Greater Mekong Subregion: A Systematic-Review and Meta-Analysis of Risk Factors Associated With Extended-Spectrum Beta-Lactamase and Carbapenemase Isolation
por: Shweta R. Singh, et al.
Publicado: (2021) -
Quantitative Insights Into β-Lactamase Inhibitor’s Contribution in the Treatment of Carbapenemase-Producing Organisms With β-Lactams
por: Yanfang Feng, et al.
Publicado: (2021)